SCHEMBL17700759

SCHEMBL17700759

CCOC(=O)CC(OC)c1cccc(O)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
F10 P00742 2/20 0.40
F2 P00734 1/20 0.40
PRSS1 P07477 1/20 0.40
HIF1A Q16665 2/20 0.39
LMNA P02545 1/20 0.39
GALR3 O60755 1/20 0.39
TSHR P16473 2/20 0.39
ALDH1A1 P00352 1/20 0.39
CA12 O43570 3/20 0.38
CA1 P00915 3/20 0.38
CA2 P00918 3/20 0.38
CA7 P43166 3/20 0.38
CA9 Q16790 3/20 0.38
CA14 Q9ULX7 3/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
HTR1A P08908 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRB3 P13945 1/20 0.38
ADRA2B P18089 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17700354 0.89 FFAR1 (0.45) F10F2PRSS1HIF1ALMNA
SCHEMBL21216026 0.87 AOC3 (0.51) F10F2PRSS1TSHRALDH1A1
SCHEMBL11078770 0.82 ALDH1A1 (0.42) F10F2PRSS1HIF1ALMNA
SCHEMBL232311 0.82 KMT2A (0.46) F10F2LMNATSHRALDH1A1
SCHEMBL5661841 0.81 F10 (0.48) F10F2PRSS1HIF1ALMNA
SCHEMBL17700667 0.81 F10 (0.46) F10F2PRSS1HIF1ALMNA
SCHEMBL17700119 0.80 KMT2A (0.55) LMNAALDH1A1
SCHEMBL3870447 0.79 HIF1A (0.43) F10F2PRSS1HIF1ALMNA
SCHEMBL25910678 0.78 SLC22A1 (0.47) HIF1ALMNAGALR3TSHRALDH1A1
SCHEMBL13882334 0.78 F10 (0.46) F10F2PRSS1HIF1ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3031799-B1 AROMATIC COMPOUND TAKEDA PHARMACEUTICALS CO (JP) 2018-04-04 EP disclosed
US-9776962-B2 Aromatic compounds with GPR40 agonistic activity TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2017-10-03 US disclosed
EP-3031799-A1 AROMATIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2016-06-15 EP disclosed
US-20160115128-A1 AROMATIC COMPOUND TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2016-04-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160115128-A1 AROMATIC COMPOUND GLP1R, GPR119, GPR39 F10 2043/4885F2 4367/4885PRSS1 1799/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.